PCK2 and Hyperglycemia: In addition to inhibiting insulin signaling, iAs also stimulates hepatic gluconeogenesis by inducing the increased expression of phosphoenolpyruvate carboxykinase (PEPCK), a rate-limiting enzyme in gluconeogenesis, thus resulting in hyperglycemia even under fasted conditions [156,157].